Partner Erika Morabito is quoted in a Law360 article, “GST AutoLeather Nears Deal on DIP Funding and Sale Plans,” about the status of the bankrupt vehicle upholstery maker’s plans to sell off its assets and wind down its operations.
Morabito, who represents the official committee of unsecured creditors, said when the parties reconvene before U.S. Bankruptcy Judge Laurie Selber Silverstein, they will either have an agreement in place to allow the sale to go through or they will be providing a further status update on the pursuit of their objections to the deal.
“While we’re not there yet, certainly what we received late last night was a much more positive and constructive step toward holistic resolution,” she said.
Morabito, who represents the official committee of unsecured creditors, said when the parties reconvene before U.S. Bankruptcy Judge Laurie Selber Silverstein, they will either have an agreement in place to allow the sale to go through or they will be providing a further status update on the pursuit of their objections to the deal.
“While we’re not there yet, certainly what we received late last night was a much more positive and constructive step toward holistic resolution,” she said.
Related News
25 July 2024
In the News
Donald Schroeder on Groff – ‘Supreme Court decision is inviting a more fact-based analysis’
Foley & Lardner LLP partner Donald Schroeder assessed the impact of the U.S. Supreme Court’s 2023 decision in a religious accommodation case as it returns to the district court in the Law360 article, “A Year After High Court Spotlight, Groff Case Still A Bellwether.”
24 July 2024
In the News
Louis Lehot Featured in Q&A on How Startups Can Prepare for IPO
Foley & Lardner LLP partner Louis Lehot features in the Q&A, "How startups can get in top shape for an IPO, according to Silicon Valley lawyer Louis Lehot," part of Business Insider's Road to IPO' series.
24 July 2024
In the News
Courtenay Brinckerhoff on Patent Cap in Drug Pricing – ‘Hard to predict if this will make a difference’
Foley & Lardner LLP partner Courtenay Brinckerhoff discussed a recent bill passed in the U.S. Senate aimed at lowering drug prices by limiting the number of patents that can be asserted in cases over biosimilars in the Law360 article, “Patent Cap In Drug Pricing Bill Seen As Having Muted Effect.”